For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and Attruby represents a true advancement . These innovative therapies stabilize the transthyretin protein, preventing its harmful build-up and reducing the impact of the disease . Individuals are now reporting positive